AKT Flashcards
1
Q
UTI in children
A
if +ve leucocytes and -ve nitrite –> <3 years start antibiotics, if >3 years only start if symptomatic
Nitro or TMP
2
Q
Pyelonephritis + Pregnant
A
cefalexin
3
Q
non lactational mastitis
A
co-amoxiclav
4
Q
AOM
A
- amoxicillin 5-7 days
- co-amoxiclav 5-7 days
5
Q
Sinusitis
A
Pen V
Co-Amoxiclav if severe
10 days of symptoms - high dose nasal steroids
21 days of symptoms - antibiotics
6
Q
perichondritis
A
ciprofloxacin
7
Q
diverticulitis
A
co-amoxiclav
8
Q
whooping cough
A
erythromycin
9
Q
HAP
A
<5 days - co-amoxiclav
>5 days - ciprofloxacin
10
Q
define AKI
A
rise in SCr by 26 in 48 hours of by 50% in 7 days
11
Q
acceptance for ACEi
A
drop in EGFR by 25% or rise in SCR by 30%
12
Q
HTN - ACR >70
A
<130/80
13
Q
referral for CKD
A
fall by 15ml/min in 12 months or reduced by 25% in 12 months
14
Q
Thiazides and CA
A
Hypercalcaemia
15
Q
Cushings and Conns K
A
hypok
16
Q
describe hydrocele
A
abive psermatic cord
anterior and inferiro to testicle
17
Q
DMARD safe in pregnancy
A
hydroxychloroquine
17
Q
hameaturia after URTI
A
IGA
18
Q
drugs not in G6PD
A
sulphonylureas and ciporfloxacin
19
Q
cervical screening
A
25-64 every 5 years
20
Q
UKMEC bmi >35
A
cocp is ukmec 3
21
Q
UKMEC bmi 30-35
A
cocp is ukmec2
22
Q
VTE and COCP
A
if personal hx –> UKMEC4
if Fhx in a first degree rleative less than 45 years –> UKMEC3
23
Q
VTE and COCP
A
if personal hx –> UKMEC4
if Fhx in a first degree rleative less than 45 years –> UKMEC3
24
>35 and smokes
>15 - UKMEC4
<15 - UKMEC3
25
abx not safe in breastfeeding
tetracyclines
ciprofloxacin
chloramphenicol
26
downs syndrome tests
10-14 weeks --> combined test
14 weeks --> quadruple test
27
GDM diagnosis
fasting >5.6, OGTT 7.8
28
HTN and T1dm
BP <130/80
29
IFG
fasting >6.1-7
30
IGT
gasting >6.1 - 7 and OGTT >7.8 - 11.1
31
weight neutral diabetic drugs
metformin and gliptins
32
orlistat rules
BMI >30 or >27 with RF
stop if not lost 5% in 3 months
33
stage 1 HTN
clinic >140/90
Home >135/85
34
stage 2 NTN
clinic >160/100
home >150/95
35
bells palsy treatment
<72 hours -- 10 days of steroids
36
peripheral nystagmus
horizontal + torsional nystagmus
37
central nystgamus
vertical + torisonal
38
breakthrough pain dose
one sixth
39
PO codeine/tramadol/dihydrocodeine to moprhine
divide by 10
40
PO morphine to PO oxycodone
divide by 1.5
41
po morphine to sc oxycodone
divide by 3
42
po morphine to subcut diamoprhine
divide by 3
43
functional BO nausea
metoclopramide
44
hbsag
active infection - acute or chronic
45
antihbc
CAUGHT - current or previous infection
46
antihbs
resolved infection - immune - vaccines
antiHBs without antiHBc is immunisised
47
proven GORd severe osoephagitis
8 weeks of full dose PPI
48
PBC ab
AMA +ve
49
PSC ab
pANCA
50
2WW >55 and weight loss and
either upper abdo pain, reflux or dyspepsia
51
2WW >40
weight loss and upper abdominal pain
52
2ww >50
rectal bleeding
53
<50 with bleeding
abdominal pain or bowel change or weight loss or IDA
54
bowel screening
50-74 years 2 hourly
55
pain on lebow extension
tennis elbow
56
MCP + PIP joints
RA
57
no plantarflexion and inversion
tibial nerve
58
when is FRAX not needed before DEXA
<40 with major risk for fragility fracture
>50 with a fragility fracture
59
when is DEXA not needed before treatment
>/75 with fragility fracture
on steroids and >65 with fragility fracture
60
when is DEXA not needed before treatment
>/75 with fragility fracture
on steroids and >65 with fragility fracture
61
antibitoics not for use in MG
quinolones
macrolides
tetracyclines
62
NICE guidance step up for asthma
low dose ics
then add lTRA
then add LABA
63
BTS guidance step up for asthma
low dose ICS
then add LABA
then add LTRA or increase dose of steroid
64
severe asthma
PEFR 33-50%
>12 -- hr >110, RR >25
>5 - RR >30 HR >125
<5 RR >40 HR >140
65
fev1 fvc obstructive
feve 1 low
fvc normal
<0.7
66
fev1 fvc restrictive
fev1 low
fvc very low
>0.7
67
herald patch
rosea
68
erythema multiforme
mycoplasma
69
pregnant anaemia
<110
70
raised APTT
haemophillia
antiphopsholipid syndrome
71
hamophillia a
viii
72
group a strep exclusion
24 hours after abx
73
whooping cough exclusion
48 hours after abx
74
impetigo
48 hours after abx or crusted
75
measles exclusion
4 days
76
rubella exclusion
5 days
77
mumps exclusion
5 days
78
chickenpox exclusion
5 days
79
confluent rash behind the ears
measles
80
semi dilated pupil
glaucoma
81
haloes
glaucoma
82
ciliary flush
anterior uveitis
83
small and irregular pupil
anterior uveitis
84
RAPD
retinal detachment and optic neuritis
85
homes aide
unilaterally dilated pupil
86
argyll robertson
small unreactive irregular pupils
87
Glaucoma risk
Hypermetropia
88
Fixed mid dilated pupil
Glaucoma
89
patch testing
type 4 reactions - contact allergic dermatitis
90
Pr interval prigressively gets longer
2nd degree - mobitz type 1
91
NICE traffc light: nasal flaring
amber
92
NICE traffic light: RR
6-12 months >50 = amber
>12 months >40 = amber
red flag > 60
93
NICe traffic light RR >60
red
94
NICE traffic light: dry mucous membranes
amber
95
NICE traffic light: HR
<1 year - >160 =amber
1-2 years - > 150 = amber
2-5 years - >140 =amber
96
belo and lateral to pubic tubercle
femoral hernia - all should be repaired
97
medial and inferiro to epigastric arteries
direct (DM)
98
lateral to epigastrid arteries
indirect (LI)
99
inguinal heria in scrotum
indirect (illy willy)
100
chalyida partner notification
symptomatic men - 4 weeks
asympatic men and women - 6 months
101
tetanus vaccine: full course confirmed and last dose <10 years ago
no vaccine or IG required
102
when to give antibiotics in acute bronchitis
>65 with 2 of OR >80 with 1 of
- diabetes
congestive heart failure
-steroid use
- hospital admission in previous 1 year
103
CHADVASC
2 points for >75 or previous stroke
start if men have 1 or women have 2
104
subclinical hyperthyroid: referral
TSH <0.1 x 2 on 3 months part
105
subclinical hyperthyroid: management
monitor TFTs every 6 months
106
high w-t-h
>0.6
107
healthy w-t-h
0.4-0.5
108
define primary amenorrhoea
no periods or boobs by 13
no periods but boobs by 15`
109
when should oestrogen contraception be stopped
aged 50
110
`perfect use and typical use: cocp and pop
perfect 0.3% typical 9%
111
perfect use and typical use: implant
0.05%
112
mild LD
50-70
113
moderate LD
35-50
114
severe
20-35
